Related Experiment Videos
Treatment of a common problem in hemodialysis patients: is the juice worth the squeeze?
Khalid Al-Saran1, Alaa Sabry, Naila Shaheen
1Prince Salman Center for Kidney, Riyadh, Saudi Arabia. Khalid_aln@yahoo.com
Insights
Hepatitis C virus (HCV) infection in hemodialysis patients is common but often asymptomatic. Management is challenging, with limited understanding of its long-term impact on this vulnerable population.
Area of Science:
- Nephrology
- Hepatology
- Public Health
Background:
- Chronic hepatitis C virus (HCV) infection poses a significant global health challenge.
- HCV infection in hemodialysis patients presents unique management difficulties and an incompletely understood natural history.
- Hemodialysis patients have a reduced life expectancy, potentially altering the typical progression of HCV-related liver disease.
Purpose of the Study:
- To review key aspects of HCV infection in chronic kidney disease (CKD) patients.
- To explore the relationship between HCV and glomerulopathy.
- To assess renal allograft outcomes in HCV-infected patients.
- To present the prevalence and treatment of HCV in Saudi Arabian hemodialysis patients.
- To share clinical experience in managing HCV-infected hemodialysis patients at PSCKD.
Main Methods:
- Literature review and discussion of existing data.
- Analysis of HCV prevalence and treatment strategies in Saudi Arabia.
- Retrospective review of patient data from Prince Salman Center for Kidney Disease (PSCKD).
Main Results:
- The frequency of advanced fibrosis or cirrhosis in hemodialysis patients with HCV ranges from 0% to 28%.
- HCV infection in this population is often asymptomatic.
- Specific data on prevalence, treatment, and outcomes in Saudi Arabia are presented.
Conclusions:
- HCV infection in hemodialysis patients requires careful consideration due to its prevalence and management challenges.
- Further research is needed to fully elucidate the natural history and optimize treatment strategies.
- Clinical experience at PSCKD provides valuable insights into managing this patient group.
Abstract:
Chronic infection with hepatitis C virus (HCV) is a serious public health problem affecting an estimated 2% of the world's population. The natural history of HCV infection in hemodialysis patients remains incompletely understood and the management is difficult. HCV infection in hemodialysis patients is usually asymptomatic. Given the diminished life expectancy of hemodialysis patients, complications such as decompensated cirrhosis and hepatocellular carcinoma may not have time to develop. The frequency of advanced fibrosis or cirrhosis ranges from 0% to 28 %. We discuss in this presentation several aspects of HCV infection in chronic kidney disease (CKD) patients such as relationship with glomerulopathy, renal allograft outcome, prevalence in hemodialysis patients in the kingdom of Saudi Arabia, treatment of HCV in hemodialysis patients in the kingdom of Saudia Arabia, and finally our experience at Prince Salman Center for kidney disease (PSCKD) in the management of HCV infected hemodialysis patients.
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Dialysis
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury V: Interprofessional Care